Vincerx Pharma, Inc. Unit
VINCU
VINCU was delisted on the 25th of March, 2021.
2 hedge funds and large institutions have $8.11M invested in Vincerx Pharma, Inc. Unit in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 5 closing their positions.
67% less funds holding
Funds holding: 6 → 2 (-4)
79% less capital invested
Capital invested by funds: $38.7M → $8.11M (-$30.6M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$8.26M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$11.3M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$9.63M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$9.57M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$7.7M |
| 5 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$540K |
VINCU Hedge Fund Activity: Q1 2021 in Review
2 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Unit (VINCU) for Q1 2021, worth a combined $8.11M — down 79% from $38.7M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VINCU and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Boxer Capital, opening a new position worth an estimated $8.26M. The largest seller was Putnam Investments, exiting entirely with an estimated $11.3M sold.
- 2 institutional investors held Vincerx Pharma, Inc. Unit (VINCU) as of Q1 2021, down from 6 in Q4 2020.
- Funds reported $8.11M of Vincerx Pharma, Inc. Unit stock for Q1 2021, down 79% quarter-over-quarter.
- 1 fund opened new Vincerx Pharma, Inc. Unit positions in Q1 2021 and 5 closed out, a net change of -4 holders.
- The largest Vincerx Pharma, Inc. Unit buyer in Q1 2021 was Boxer Capital, an estimated $8.26M added.
- The largest Vincerx Pharma, Inc. Unit seller in Q1 2021 was Putnam Investments, an estimated $11.3M sold.
Based on aggregated 13F filings for Q1 2021.